

 
                    "Advancing obesity and obesity-related trials with patients at the center of development.
LEARN MORE 
                Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview 
                Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW 
                Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW 
                Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW 
                When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS 
                By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE 
                Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE 
                Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE 
                The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE 
                The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE 
                IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE 
                Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE 
                    "At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESOn June 28, IQVIA Spain celebrated the First Biotech Companies IQVIA Forum entitled ‘How to maximize the value of my product through a good Clinical Development Strategy?’
The forum began with the presentation of Antonio Vila-Coro, Account Director Emerging Pharma of IQVIA, who had the initiative to carry out the event with the idea that small biotechnology companies could learn a lot from Big Pharma.
Carolina Rubel, Clinical Project Management Director of IQVIA, spoke about the design of the clinical strategy to maximize the value of the product under development and the importance of the initial phase of the analysis. She explained that the Target Product Profile (TPP) can be use to design the clinical strategy.
Finally, José González Martínez, Associate Principal, Consulting Service, Strategy & Portfolio Analysis of IQVIA, explained the economic aspects of clinical development. González highlighted the importance of being prepared for the questions that the investors may have and stated that ‘product risk’ is one of the factors that interests most.
The forum was broadcast via Twitter using the hashtag #ForoEBP.



